Document and Entity Information
Document and Entity Information - shares | 3 Months Ended | |
Mar. 31, 2024 | May 14, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2024 | |
Current Fiscal Year End Date | --12-31 | |
Document Fiscal Year Focus | 2024 | |
Document Fiscal Period Focus | Q1 | |
Document Transition Report | false | |
Entity File Number | 1-8601 | |
Entity Registrant Name | CreditRiskMonitor.com, Inc. | |
Entity Central Index Key | 0000315958 | |
Entity Incorporation, State or Country Code | NV | |
Entity Tax Identification Number | 36-2972588 | |
Entity Address, Address Line One | 704 Executive Boulevard | |
Entity Address, Address Line Two | Suite A | |
Entity Address, City or Town | Valley Cottage | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10989 | |
City Area Code | 845 | |
Local Phone Number | 230-3000 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 10,722,401 |
CONDENSED BALANCE SHEETS
CONDENSED BALANCE SHEETS - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
Current assets: | ||
Cash and cash equivalents | $ 11,416,118 | $ 11,004,937 |
Held-to-maturity securities - treasury bills | 3,538,990 | 3,494,958 |
Accounts receivable, net of allowance of $30,000 | 3,792,728 | 3,941,182 |
Other current assets | 806,697 | 788,722 |
Total current assets | 19,554,533 | 19,229,799 |
Held-to-maturity securities - treasury bills | 700,000 | 700,000 |
Property and equipment, net | 661,728 | 557,634 |
Operating lease right-to-use asset | 1,560,109 | 1,612,512 |
Goodwill | 1,954,460 | 1,954,460 |
Other assets | 18,110 | 18,110 |
Total assets | 24,448,940 | 24,072,515 |
Current liabilities: | ||
Unexpired subscription revenue | 11,114,177 | 10,272,352 |
Accounts payable | 238,181 | 141,956 |
Current portion of operating lease liability | 216,035 | 211,488 |
Accrued expenses | 1,314,751 | 2,105,019 |
Total current liabilities | 12,883,144 | 12,730,815 |
Deferred taxes on income, net | 350,605 | 350,605 |
Unexpired subscription revenue, less current portion | 195,864 | 68,523 |
Operating lease liability, less current portion | 1,499,041 | 1,554,686 |
Total liabilities | 14,928,654 | 14,704,629 |
Stockholders' equity: | ||
Preferred stock, $.01 par value; authorized 5,000,000 shares; none issued | 0 | 0 |
Common stock, $.01 par value; authorized 32,500,000 shares; issued and outstanding 10,722,401 shares | 107,224 | 107,224 |
Additional paid-in capital | 30,032,766 | 30,007,773 |
Accumulated deficit | (20,619,704) | (20,747,111) |
Total stockholders' equity | 9,520,286 | 9,367,886 |
Total liabilities and stockholders' equity | $ 24,448,940 | $ 24,072,515 |
CONDENSED BALANCE SHEETS (Paren
CONDENSED BALANCE SHEETS (Parenthetical) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
Current assets: | ||
Accounts receivable, allowance | $ 30,000 | $ 30,000 |
Stockholders' equity: | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, issued (in shares) | 0 | 0 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, authorized (in shares) | 32,500,000 | 32,500,000 |
Common stock, issued (in shares) | 10,722,401 | 10,722,401 |
Common stock, outstanding (in shares) | 10,722,401 | 10,722,401 |
CONDENSED STATEMENTS OF OPERATI
CONDENSED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
CONDENSED STATEMENTS OF OPERATIONS [Abstract] | ||
Operating revenues | $ 4,808,707 | $ 4,590,744 |
Operating expenses: | ||
Data and product costs | 2,197,777 | 1,920,371 |
Selling, general and administrative expenses | 2,553,601 | 2,359,041 |
Depreciation and amortization | 93,170 | 97,521 |
Total operating expenses | 4,844,548 | 4,376,933 |
(Loss) income from operations | (35,841) | 213,811 |
Other income | 201,759 | 140,978 |
Income before income taxes | 165,918 | 354,789 |
Provision for income taxes | (38,511) | (79,509) |
Net income | $ 127,407 | $ 275,280 |
Net income per share - Basic (in dollars per share) | $ 0.01 | $ 0.03 |
Net income per share - Diluted (in dollars per share) | $ 0.01 | $ 0.03 |
Weighted average number of common shares outstanding - Basic (in shares) | 10,722,401 | 10,722,401 |
Weighted average number of common shares outstanding - Diluted (in shares) | 10,766,909 | 10,797,101 |
CONDENSED STATEMENTS OF STOCKHO
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | Accumulated Deficit [Member] | Total |
Balance at Dec. 31, 2022 | $ 107,224 | $ 29,904,675 | $ (22,442,164) | $ 7,569,735 |
Balance (in shares) at Dec. 31, 2022 | 10,722,401 | |||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Net income | $ 0 | 0 | 275,280 | 275,280 |
Stock-based compensation | 0 | 27,901 | 0 | 27,901 |
Balance at Mar. 31, 2023 | $ 107,224 | 29,932,576 | (22,166,884) | 7,872,916 |
Balance (in shares) at Mar. 31, 2023 | 10,722,401 | |||
Balance at Dec. 31, 2023 | $ 107,224 | 30,007,773 | (20,747,111) | $ 9,367,886 |
Balance (in shares) at Dec. 31, 2023 | 10,722,401 | 10,722,401 | ||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||
Net income | $ 0 | 0 | 127,407 | $ 127,407 |
Stock-based compensation | 0 | 24,993 | 0 | 24,993 |
Balance at Mar. 31, 2024 | $ 107,224 | $ 30,032,766 | $ (20,619,704) | $ 9,520,286 |
Balance (in shares) at Mar. 31, 2024 | 10,722,401 | 10,722,401 |
CONDENSED STATEMENTS OF CASH FL
CONDENSED STATEMENTS OF CASH FLOWS - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Cash flows from operating activities: | ||
Net income | $ 127,407 | $ 275,280 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
Amortization of bond discount | (43,704) | (36,932) |
Depreciation and amortization | 93,170 | 97,521 |
Operating lease right-to-use asset, net | 1,305 | 3,371 |
Stock-based compensation | 24,993 | 27,901 |
Changes in operating assets and liabilities: | ||
Accounts receivable | 148,454 | 93,364 |
Other current assets | (17,975) | (10,461) |
Unexpired subscription revenue | 969,166 | 521,358 |
Accounts payable | 96,225 | (123,759) |
Accrued expenses | (790,267) | (1,022,718) |
Net cash provided by (used in) operating activities | 608,774 | (175,075) |
Cash flows from investing activities: | ||
Proceeds from held-to-maturity securities - treasury bills | 940,000 | 1,450,000 |
Purchase of held-to-maturity securities - treasury bills | (940,329) | (1,443,995) |
Purchase of property and equipment | (197,264) | (53,661) |
Net cash used in investing activities | (197,593) | (47,656) |
Net increase (decrease) in cash and cash equivalents | 411,181 | (222,731) |
Cash and cash equivalents at beginning of period | 11,004,937 | 9,866,628 |
Cash and cash equivalents at end of period | $ 11,416,118 | $ 9,643,897 |
Basis of Presentation
Basis of Presentation | 3 Months Ended |
Mar. 31, 2024 | |
Basis of Presentation [Abstract] | |
Basis of Presentation | (1) Basis of Presentation The accompanying unaudited condensed financial statements of CreditRiskMonitor.com, Inc. (the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Certain information and footnote disclosure required by generally accepted accounting principles (“GAAP”) in the United States for complete financial statements have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). In the opinion of management, the accompanying unaudited condensed financial statements reflect all material adjustments, including normal recurring accruals, necessary to present fairly the Company’s financial position, results of operations and cash flows for the periods presented, and have been prepared in a manner consistent with the audited financial statements for the fiscal year ended December 31, 2023. The results of operations for the three months ended March 31, 2024 and 2023 are not necessarily indicative of the results for an entire fiscal year. The December 31, 2023 condensed balance sheet has been derived from the audited financial statements at that date, but does not include all disclosures required by GAAP. These condensed financial statements should be read in conjunction with the audited financial statements and the footnotes for the fiscal year ended December 31, 2023 included in the Company’s Annual Report on Form 10-K. |
Recently Issued Accounting Stan
Recently Issued Accounting Standards | 3 Months Ended |
Mar. 31, 2024 | |
Recently Issued Accounting Standards [Abstract] | |
Recently Issued Accounting Standards | (2) Recently Issued Accounting Standards The Financial Accounting Standards Board (“FASB”) and the SEC have issued certain accounting pronouncements that will become effective in subsequent periods; however, management does not believe that any of those pronouncements would have significantly affected the Company’s financial accounting measurements or disclosures had they been in effect during the interim periods for which condensed financial statements are included in this quarterly report. Management also believes those pronouncements will not have a significant effect on the Company’s future financial position or results of operations. |
Revenue Recognition
Revenue Recognition | 3 Months Ended |
Mar. 31, 2024 | |
Revenue Recognition [Abstract] | |
Revenue Recognition | (3) Revenue Recognition The Company applies FASB Accounting Standards Codification (“ASC”) 606, Revenue from Contract with Customers |
Stock-Based Compensation
Stock-Based Compensation | 3 Months Ended |
Mar. 31, 2024 | |
Stock-Based Compensation [Abstract] | |
Stock-Based Compensation | (4) Stock-Based Compensation The Company applies ASC 718, Compensation-Stock Compensation The following table summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three months ended March 31: 3 Months Ended March 31, 2024 2023 Data and product costs $ 7,594 $ 10,272 Selling, general and administrative expenses 17,399 17,629 $ 24,993 $ 27,901 |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2024 | |
Fair Value Measurements [Abstract] | |
Fair Value Measurements | (5) Fair Value Measurements The Company’s cash, cash equivalents and marketable securities are stated at fair value. The carrying value of accounts receivable, other current assets, accrued expenses, and accounts payable approximates fair market value because of the short maturity of these financial instruments. The Company’s cash equivalents are generally classified within Level 1 of the fair value hierarchy because they are valued using quoted market prices. All held-to-maturity securities as of March 31, 2024 were US Treasury and federal bonds. Investments in these bonds are based on quoted market prices in active markets, and are included in the Level 1 fair value hierarchy. The tables below set forth the Company’s cash and cash equivalents, as well as marketable securities as of March 31, 2024 and December 31, 2023, respectively, which are measured at fair value on a recurring basis by level within the fair value hierarchy. March 31 2024 Level 1 Level 2 Level 3 Total Cash and cash equivalents $ 11,416,118 $ - $ - $ 11,416,118 Held-to-maturity securities 4,238,990 - - 4,238,990 $ 15,655,108 $ - $ - $ 15,655,108 December 31, 2023 Level 1 Level 2 Level 3 Total Cash and cash equivalents $ 11,004,937 $ - $ - $ 11,004,937 Held-to-maturity securities 4,194,958 - - 4,194,958 $ 15,199,895 $ - $ - $ 15,199,895 The Company did not hold financial assets and liabilities which were recorded at fair value in the Level 2 or 3 categories as of March 31, 2024. The preceding methods may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date. |
Marketable Securities
Marketable Securities | 3 Months Ended |
Mar. 31, 2024 | |
Marketable Securities [Abstract] | |
Marketable Securities | (6) Marketable Securities Based upon the Company’s intent and ability to hold its US Treasury and federal bond securities to maturity (which maturities range up to 22 months at purchase), such securities have been classified as held-to-maturity and are carried at amortized cost, which approximates fair market value. Accrued bond interest receivable as of March 31, 2024 is $3,043. The following table summarizes the cost and fair value of marketable securities at March 31, 2024 as follows: Amortized Cost Gross Unrealized Gain (Loss) Fair Value Held-to-maturity securities US Treasuries $ 4,238,990 $ 78,010 $ 4,317,000 Maturities of marketable securities were as follows at March 31, 2024: Held-to-maturity securities: Due in one year or less $ 3,538,990 Due in 12 – 24 months 700,000 $ 4,238,990 The Company’s investments in marketable securities consist primarily of investments in US Treasury securities and federal bonds. Market values were determined for each individual security in the investment portfolio. Management evaluates securities for other-than-temporary impairment at least on an annual basis, and more frequently when economic or market concerns warrant such evaluation. Consideration is given to (1) the length of time and the extent to which the fair value has been less than cost, (2) the financial condition and near-term prospects of the issuer, and (3) the intent and ability of the Company to retain its investment in the issuer for a period of time sufficient to allow for any anticipated recovery in fair value. Management has determined that no other-than-temporary impairment exists as of March 31, 2024. |
Net Income per Share
Net Income per Share | 3 Months Ended |
Mar. 31, 2024 | |
Net Income per Share [Abstract] | |
Net Income per Share | (7) Net Income per Share Basic net income per share is based on the weighted average number of common shares outstanding. Diluted net income per share is based on the weighted average number of common shares outstanding and the dilutive effect of outstanding stock options. 3 Months Ended March 31 2024 2023 Weighted average number of common shares outstanding – basic 10,722,401 10,722,401 Potential shares exercisable under stock option plans 258,000 306,650 LESS: Shares which could be repurchased under treasury stock method (213,492 ) (231,950 ) Weighted average number of common shares outstanding – diluted 10,766,909 10,797,101 For the three months ended March 31, 2024, the computation of diluted net income per share excludes the effects of the assumed exercise of 529,900 since their inclusion would be anti-dilutive as their exercise pri For the three months ended March 31, 2023, the computation of diluted net income per share excludes the effects of the assumed exercise of 379,900 options since their inclusion would be anti-dilutive as their exercise prices were above market value. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2024 | |
Commitments and Contingencies [Abstract] | |
Commitments and Contingencies | (8) Commitments and Contingencies From time to time, the Company is involved in various legal proceedings arising in the ordinary course of business. The Company records a liability when it believes that a loss will be incurred and the amount of loss or range of loss can be reasonably estimated. Based on the currently available information, the Company does not believe that there are claims or legal proceedings that would have a material adverse effect on the business, or the condensed financial statements of the Company. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2024 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | (9) Related Party Transactions On May 1, 2023, the Company’s Board of Directors appointed Michael Flum, age 36, to serve as Chief Executive Officer and President. Michael Flum joined the Company in June 2018 as Vice President of Operations & Alternative Data. He was appointed Chief Operating Officer in October 2019 and subsequently President in October 2020. Mr. Flum is the son of Jerome S. Flum, the Company’s former Chief Executive Officer and current Chairman of the Board of Directors, and the brother of Joshua Flum, a Director of the Company. |
Supplemental Disclosures of Non
Supplemental Disclosures of Noncash Investing Activities | 3 Months Ended |
Mar. 31, 2024 | |
Supplemental Disclosures of Noncash Investing Activities [Abstract] | |
Supplemental Disclosures of Noncash Investing Activities | (10) Supplemental Disclosures of Noncash Investing Activities For the three months ended March 31, 2023, there was a noncash transfer of deposits from operating activities to property and equipment in the amount of $155,700. |
Insider Trading Arrangement
Insider Trading Arrangement | 3 Months Ended |
Mar. 31, 2024 | |
Insider Trading Arrangements [Line Items] | |
Rule 10b5-1 Arrangement Adopted | false |
Non-Rule 10b5-1 Arrangement Adopted | false |
Rule 10b5-1 Arrangement Terminated | false |
Non-Rule 10b5-1 Arrangement Terminated | false |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Stock-Based Compensation [Abstract] | |
Stock-based Compensation Expense for Stock Options | The following table summarizes the stock-based compensation expense for stock options that was recorded in the Company’s results of operations in accordance with ASC 718 for the three months ended March 31: 3 Months Ended March 31, 2024 2023 Data and product costs $ 7,594 $ 10,272 Selling, general and administrative expenses 17,399 17,629 $ 24,993 $ 27,901 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Fair Value Measurements [Abstract] | |
Cash and Cash Equivalents and Marketable Securities Measured at Fair Value on Recurring Basis | The tables below set forth the Company’s cash and cash equivalents, as well as marketable securities as of March 31, 2024 and December 31, 2023, respectively, which are measured at fair value on a recurring basis by level within the fair value hierarchy. March 31 2024 Level 1 Level 2 Level 3 Total Cash and cash equivalents $ 11,416,118 $ - $ - $ 11,416,118 Held-to-maturity securities 4,238,990 - - 4,238,990 $ 15,655,108 $ - $ - $ 15,655,108 December 31, 2023 Level 1 Level 2 Level 3 Total Cash and cash equivalents $ 11,004,937 $ - $ - $ 11,004,937 Held-to-maturity securities 4,194,958 - - 4,194,958 $ 15,199,895 $ - $ - $ 15,199,895 |
Marketable Securities (Tables)
Marketable Securities (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Marketable Securities [Abstract] | |
Cost and Fair Value of Marketable Securities | The following table summarizes the cost and fair value of marketable securities at March 31, 2024 as follows: Amortized Cost Gross Unrealized Gain (Loss) Fair Value Held-to-maturity securities US Treasuries $ 4,238,990 $ 78,010 $ 4,317,000 |
Maturities of Marketable Securities | Maturities of marketable securities were as follows at March 31, 2024: Held-to-maturity securities: Due in one year or less $ 3,538,990 Due in 12 – 24 months 700,000 $ 4,238,990 |
Net Income per Share (Tables)
Net Income per Share (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Net Income per Share [Abstract] | |
Computation of Basic and Diluted Net Income per Share | Basic net income per share is based on the weighted average number of common shares outstanding. Diluted net income per share is based on the weighted average number of common shares outstanding and the dilutive effect of outstanding stock options. 3 Months Ended March 31 2024 2023 Weighted average number of common shares outstanding – basic 10,722,401 10,722,401 Potential shares exercisable under stock option plans 258,000 306,650 LESS: Shares which could be repurchased under treasury stock method (213,492 ) (231,950 ) Weighted average number of common shares outstanding – diluted 10,766,909 10,797,101 |
Stock-Based Compensation (Detai
Stock-Based Compensation (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Stock-Based Compensation Expense for Stock Options [Abstract] | ||
Stock-based compensation expense | $ 24,993 | $ 27,901 |
Data and Product Costs [Member] | ||
Stock-Based Compensation Expense for Stock Options [Abstract] | ||
Stock-based compensation expense | 7,594 | 10,272 |
Selling, General and Administrative Expenses [Member] | ||
Stock-Based Compensation Expense for Stock Options [Abstract] | ||
Stock-based compensation expense | $ 17,399 | $ 17,629 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) - Recurring [Member] - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
Cash and Cash Equivalents and Marketable Securities Measured at Fair Value on Recurring Basis [Abstract] | ||
Cash and cash equivalents | $ 11,416,118 | $ 11,004,937 |
Held-to-maturity securities | 4,238,990 | 4,194,958 |
Fair Value | 15,655,108 | 15,199,895 |
Level 1 [Member] | ||
Cash and Cash Equivalents and Marketable Securities Measured at Fair Value on Recurring Basis [Abstract] | ||
Cash and cash equivalents | 11,416,118 | 11,004,937 |
Held-to-maturity securities | 4,238,990 | 4,194,958 |
Fair Value | 15,655,108 | 15,199,895 |
Level 2 [Member] | ||
Cash and Cash Equivalents and Marketable Securities Measured at Fair Value on Recurring Basis [Abstract] | ||
Cash and cash equivalents | 0 | 0 |
Held-to-maturity securities | 0 | 0 |
Fair Value | 0 | 0 |
Level 3 [Member] | ||
Cash and Cash Equivalents and Marketable Securities Measured at Fair Value on Recurring Basis [Abstract] | ||
Cash and cash equivalents | 0 | 0 |
Held-to-maturity securities | 0 | 0 |
Fair Value | $ 0 | $ 0 |
Marketable Securities, Cost and
Marketable Securities, Cost and Fair Value of Marketable Securities (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Dec. 31, 2023 | |
Debt Securities, Held-to-Maturity, Fair Value [Abstract] | ||
Amortized Cost | $ 3,538,990 | $ 3,494,958 |
Accrued bond interest receivable | 3,043 | |
US Treasuries [Member] | ||
Debt Securities, Held-to-Maturity, Fair Value [Abstract] | ||
Amortized Cost | 4,238,990 | |
Gross Unrealized Gain (Loss) | 78,010 | |
Fair Value | $ 4,317,000 |
Marketable Securities, Maturiti
Marketable Securities, Maturities of Marketable Securities (Details) | 3 Months Ended |
Mar. 31, 2024 USD ($) | |
Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Maturity, Allocated and Single Maturity Date [Abstract] | |
Due in one year or less | $ 3,538,990 |
Due in 12 - 24 months | 700,000 |
Held-to-maturity securities | 4,238,990 |
Other-than-temporary impairment loss | $ 0 |
Net Income per Share (Details)
Net Income per Share (Details) - shares | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Net Income per Share [Abstract] | ||
Weighted average number of common shares outstanding - basic (in shares) | 10,722,401 | 10,722,401 |
Potential shares exercisable under stock option plans (in shares) | 258,000 | 306,650 |
Less: Shares which could be repurchased under treasury stock method (in shares) | (213,492) | (231,950) |
Weighted average number of common shares outstanding - diluted (in shares) | 10,766,909 | 10,797,101 |
Stock Options [Member] | ||
Antidilutive Securities Excluded from Computation [Abstract] | ||
Antidilutive securities excluded from computation of earnings per share (in shares) | 529,900 | 379,900 |
Supplemental Disclosures of N_2
Supplemental Disclosures of Noncash Investing Activities (Details) | 3 Months Ended |
Mar. 31, 2023 USD ($) | |
Supplemental Disclosures of Noncash Investing Activities [Abstract] | |
Noncash transfer of prepaids | $ 155,700 |